AZD9668 Relative Bioavailability

• Status: Completed
• Trial end date: 2009-12-01

Summary

This clinical study will aid future formulation development and optimisation of AZD9668 tablets by evaluating possible effects of minor changes to the formulation and process on the rate and extent of absorption.

• Phase: Phase 1

Details

• Lead Sponsor: AstraZeneca